Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04136353 |
|---|---|
| Brief Title: | Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate (DASL-HiCaP) |
| First Submitted : | October 17, 2019 |
| First Submitted that Met QC Criteria : | October 21, 2019 |
| First Posted : | October 23, 2019 |
| Last Update Submitted that Met QC Criteria : | February 1, 2023 |
| Last Update Posted : | February 3, 2023 (Estimate) |